Literature DB >> 32421762

Impact of Community Treatment With Ivermectin for the Control of Scabies on the Prevalence of Antibodies to Strongyloides stercoralis in Children.

Michael Marks1,2, Sarah Gwyn3, Hilary Toloka4, Christian Kositz1, James Asugeni4, Rowena Asugeni4, Jason Diau4, John M Kaldor5, Lucia Romani5, Michelle Redman-MacLaren6, David MacLaren6, Anthony W Solomon1,2, David C W Mabey1,2, Andrew C Steer7,8,9, Diana Martin3.   

Abstract

The prevalence of antibodies to Strongyloides stercoralis was measured in 0-12-year-olds using a bead-based immunoassay before and after ivermectin mass drug administration (MDA) for scabies in the Solomon Islands. Seroprevalence was 9.3% before and 5.1% after MDA (P = .019), demonstrating collateral benefits of ivermectin MDA in this setting.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America.

Entities:  

Keywords:  Strongyloides; ivermectin; neglected tropical diseases; scabies

Year:  2020        PMID： 32421762      PMCID： PMC7819519          DOI： 10.1093/cid/ciaa584

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  13 in total

1.  Multiple-dose versus single-dose ivermectin for Strongyloides stercoralis infection (Strong Treat 1 to 4): a multicentre, open-label, phase 3, randomised controlled superiority trial.

Authors:  Dora Buonfrate; Joaquin Salas-Coronas; José Muñoz; Begoña Trevino Maruri; Paola Rodari; Francesco Castelli; Lorenzo Zammarchi; Leila Bianchi; Federico Gobbi; Teresa Cabezas-Fernández; Ana Requena-Mendez; Gauri Godbole; Ronaldo Silva; Marilena Romero; Peter L Chiodini; Zeno Bisoffi
Journal:  Lancet Infect Dis       Date:  2019-09-23       Impact factor: 25.071

Review 2.  Human strongyloidiasis.

Authors:  D I Grove
Journal:  Adv Parasitol       Date:  1996       Impact factor: 3.870

3.  Efficacy of Moxidectin Versus Ivermectin Against Strongyloides stercoralis Infections: A Randomized, Controlled Noninferiority Trial.

Authors:  Beatrice Barda; Somphou Sayasone; Khampheng Phongluxa; Syda Xayavong; Khonsavanh Keoduangsy; Peter Odermatt; Maxim Puchkov; Jörg Huwyler; Jan Hattendorf; Jennifer Keiser
Journal:  Clin Infect Dis       Date:  2017-07-15       Impact factor: 9.079

4.  Accuracy of five serologic tests for the follow up of Strongyloides stercoralis infection.

Authors:  Dora Buonfrate; Marco Sequi; Rojelio Mejia; Ruben O Cimino; Alejandro J Krolewiecki; Marco Albonico; Monica Degani; Stefano Tais; Andrea Angheben; Ana Requena-Mendez; José Muñoz; Thomas B Nutman; Zeno Bisoffi
Journal:  PLoS Negl Trop Dis       Date:  2015-02-10

5.  Strongyloides seroprevalence before and after an ivermectin mass drug administration in a remote Australian Aboriginal community.

Authors:  Therese M Kearns; Bart J Currie; Allen C Cheng; James McCarthy; Jonathan R Carapetis; Deborah C Holt; Wendy Page; Jennifer Shield; Roslyn Gundjirryirr; Eddie Mulholland; Linda Ward; Ross M Andrews
Journal:  PLoS Negl Trop Dis       Date:  2017-05-15

6.  Preclinical Study of Single-Dose Moxidectin, a New Oral Treatment for Scabies: Efficacy, Safety, and Pharmacokinetics Compared to Two-Dose Ivermectin in a Porcine Model.

Authors:  Charlotte Bernigaud; Fang Fang; Katja Fischer; Anne Lespine; Ludwig Serge Aho; Dominique Dreau; Andrew Kelly; Jean-François Sutra; Francis Moreau; Thomas Lilin; Françoise Botterel; Jacques Guillot; Olivier Chosidow
Journal:  PLoS Negl Trop Dis       Date:  2016-10-12

7.  Randomized Trial of Community Treatment With Azithromycin and Ivermectin Mass Drug Administration for Control of Scabies and Impetigo.

Authors:  Michael Marks; Hilary Toloka; Ciara Baker; Christian Kositz; James Asugeni; Elliot Puiahi; Rowena Asugeni; Kristy Azzopardi; Jason Diau; John M Kaldor; Lucia Romani; Michelle Redman-MacLaren; David MacLaren; Anthony W Solomon; David C W Mabey; Andrew C Steer
Journal:  Clin Infect Dis       Date:  2019-03-05       Impact factor: 9.079

8.  Efficacy of mass drug administration with ivermectin for control of scabies and impetigo, with coadministration of azithromycin: a single-arm community intervention trial.

Authors:  Lucia Romani; Michael Marks; Oliver Sokana; Titus Nasi; Bakaai Kamoriki; Billie Cordell; Handan Wand; Margot J Whitfeld; Daniel Engelman; Anthony W Solomon; John M Kaldor; Andrew C Steer
Journal:  Lancet Infect Dis       Date:  2019-04-04       Impact factor: 71.421

9.  African Program for Onchocerciasis Control 1995-2010: Impact of Annual Ivermectin Mass Treatment on Off-Target Infectious Diseases.

Authors:  Stanimira P Krotneva; Luc E Coffeng; Mounkaila Noma; Honorat G M Zouré; Lalle Bakoné; Uche V Amazigo; Sake J de Vlas; Wilma A Stolk
Journal:  PLoS Negl Trop Dis       Date:  2015-09-24

10.  Impact of Enhanced Health Interventions for United States-Bound Refugees: Evaluating Best Practices in Migration Health.

Authors:  Tarissa Mitchell; Deborah Lee; Michelle Weinberg; Christina Phares; Nicola James; Kittisak Amornpaisarnloet; Lalita Aumpipat; Gretchen Cooley; Anita Davies; Valerie Daw Tin Shwe; Vasil Gajdadziev; Olga Gorbacheva; Chutharat Khwan-Niam; Alexander Klosovsky; Waritorn Madilokkowit; Diana Martin; Naing Zaw Htun Myint; Thi Ngoc Yen Nguyen; Thomas B Nutman; Elise M O'Connell; Luis Ortega; Sugunya Prayadsab; Chetdanai Srimanee; Wasant Supakunatom; Vattanachai Vesessmith; William M Stauffer
Journal:  Am J Trop Med Hyg       Date:  2017-12-14       Impact factor: 2.345
View more
  3 in total

1.  Evaluation of antibody serology to determine current helminth and Plasmodium falciparum infections in a co-endemic area in Southern Mozambique.

Authors:  Rebeca Santano; Rocío Rubio; Berta Grau-Pujol; Valdemiro Escola; Osvaldo Muchisse; Inocência Cuamba; Marta Vidal; Gemma Ruiz-Olalla; Ruth Aguilar; Javier Gandasegui; Maria Demontis; Jose Carlos Jamine; Anélsio Cossa; Charfudin Sacoor; Jorge Cano; Luis Izquierdo; Chetan E Chitnis; Ross L Coppel; Virander Chauhan; David Cavanagh; Sheetij Dutta; Evelina Angov; Lisette van Lieshout; Bin Zhan; José Muñoz; Carlota Dobaño; Gemma Moncunill
Journal:  PLoS Negl Trop Dis       Date:  2022-06-21

Review 2.  Broadening the range of use cases for ivermectin - a review of the evidence.

Authors:  Christian Kositz; John Bradley; Harry Hutchins; Anna Last; Umberto D'Alessandro; Michael Marks
Journal:  Trans R Soc Trop Med Hyg       Date:  2022-03-02       Impact factor: 2.455

Review 3.  Are current preventive chemotherapy strategies for controlling and eliminating neglected tropical diseases cost-effective?

Authors:  Hugo C Turner; Wilma A Stolk; Anthony W Solomon; Jonathan D King; Antonio Montresor; David H Molyneux; Jaspreet Toor
Journal:  BMJ Glob Health       Date:  2021-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.